232 related articles for article (PubMed ID: 21453388)
21. Protective effect of cytotoxic T lymphocytes targeting HTLV-1 bZIP factor.
Sugata K; Yasunaga J; Mitobe Y; Miura M; Miyazato P; Kohara M; Matsuoka M
Blood; 2015 Aug; 126(9):1095-105. PubMed ID: 26063164
[TBL] [Abstract][Full Text] [Related]
22. The Role of HBZ in HTLV-1-Induced Oncogenesis.
Zhao T
Viruses; 2016 Feb; 8(2):. PubMed ID: 26848677
[TBL] [Abstract][Full Text] [Related]
23. Assessment of
Fajami Z; Akbarin MM; Rafatpanah H; Ramezani S; Rahimi H; Rezaee SA
AIDS Res Hum Retroviruses; 2024 Mar; 40(3):141-147. PubMed ID: 37565279
[TBL] [Abstract][Full Text] [Related]
24. Expression of a protein involved in bone resorption, Dkk1, is activated by HTLV-1 bZIP factor through its activation domain.
Polakowski N; Gregory H; Mesnard JM; Lemasson I
Retrovirology; 2010 Jul; 7():61. PubMed ID: 20653953
[TBL] [Abstract][Full Text] [Related]
25. Does the HBZ gene represent a new potential target for the treatment of adult T-cell leukemia?
Barbeau B; Mesnard JM
Int Rev Immunol; 2007; 26(5-6):283-304. PubMed ID: 18027202
[TBL] [Abstract][Full Text] [Related]
26. Molecular Pathology of Adult T-Cell Leukemia/Lymphoma.
Ohshima K
Oncology; 2015; 89 Suppl 1():7-15. PubMed ID: 26550829
[TBL] [Abstract][Full Text] [Related]
27. HTLV-1 bZIP factor enhances TGF-β signaling through p300 coactivator.
Zhao T; Satou Y; Sugata K; Miyazato P; Green PL; Imamura T; Matsuoka M
Blood; 2011 Aug; 118(7):1865-76. PubMed ID: 21705495
[TBL] [Abstract][Full Text] [Related]
28. Effects of valproate on Tax and HBZ expression in HTLV-1 and HAM/TSP T lymphocytes.
Belrose G; Gross A; Olindo S; Lézin A; Dueymes M; Komla-Soukha I; Smadja D; Tanaka Y; Willems L; Mesnard JM; Peloponese JM; Césaire R
Blood; 2011 Sep; 118(9):2483-91. PubMed ID: 21505188
[TBL] [Abstract][Full Text] [Related]
29. A novel alternative splicing isoform of human T-cell leukemia virus type 1 bZIP factor (HBZ-SI) targets distinct subnuclear localization.
Murata K; Hayashibara T; Sugahara K; Uemura A; Yamaguchi T; Harasawa H; Hasegawa H; Tsuruda K; Okazaki T; Koji T; Miyanishi T; Yamada Y; Kamihira S
J Virol; 2006 Mar; 80(5):2495-505. PubMed ID: 16474156
[TBL] [Abstract][Full Text] [Related]
30. Increased expression of HBZ and Foxp3 mRNA in bronchoalveolar lavage cells taken from human T-lymphotropic virus type 1-associated lung disorder patients.
Nakayama Y; Yamazato Y; Tamayose M; Atsumi E; Yara S; Higa F; Tateyama M; Fujita J
Intern Med; 2013; 52(23):2599-609. PubMed ID: 24292748
[TBL] [Abstract][Full Text] [Related]
31. The HTLV-1 viral oncoproteins Tax and HBZ reprogram the cellular mRNA splicing landscape.
Vandermeulen C; O'Grady T; Wayet J; Galvan B; Maseko S; Cherkaoui M; Desbuleux A; Coppin G; Olivet J; Ben Ameur L; Kataoka K; Ogawa S; Hermine O; Marcais A; Thiry M; Mortreux F; Calderwood MA; Van Weyenbergh J; Peloponese JM; Charloteaux B; Van den Broeke A; Hill DE; Vidal M; Dequiedt F; Twizere JC
PLoS Pathog; 2021 Sep; 17(9):e1009919. PubMed ID: 34543356
[TBL] [Abstract][Full Text] [Related]
32. HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT).
Yasuma K; Yasunaga J; Takemoto K; Sugata K; Mitobe Y; Takenouchi N; Nakagawa M; Suzuki Y; Matsuoka M
PLoS Pathog; 2016 Jan; 12(1):e1005372. PubMed ID: 26735971
[TBL] [Abstract][Full Text] [Related]
33. Detection of human T-lymphotropic virus type-I DNA and mRNA in the lymph nodes; using polymerase chain reaction in situ hybridization (PCR/ISH) and reverse transcription (RT-PCR/ISH).
Ohshima K; Suzumiya J; Izumo S; Mukai Y; Tashiro K; Kikuchi M
Int J Cancer; 1996 Mar; 66(1):18-23. PubMed ID: 8608960
[TBL] [Abstract][Full Text] [Related]
34. Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/Lymphoma.
Nakagawa M; Shaffer AL; Ceribelli M; Zhang M; Wright G; Huang DW; Xiao W; Powell J; Petrus MN; Yang Y; Phelan JD; Kohlhammer H; Dubois SP; Yoo HM; Bachy E; Webster DE; Yang Y; Xu W; Yu X; Zhao H; Bryant BR; Shimono J; Ishio T; Maeda M; Green PL; Waldmann TA; Staudt LM
Cancer Cell; 2018 Aug; 34(2):286-297.e10. PubMed ID: 30057145
[TBL] [Abstract][Full Text] [Related]
35. HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein.
Matsumoto J; Ohshima T; Isono O; Shimotohno K
Oncogene; 2005 Feb; 24(6):1001-10. PubMed ID: 15592508
[TBL] [Abstract][Full Text] [Related]
36. HTLV-1 bZIP factor: the key viral gene for pathogenesis.
Matsuoka M; Mesnard JM
Retrovirology; 2020 Jan; 17(1):2. PubMed ID: 31915026
[TBL] [Abstract][Full Text] [Related]
37. HTLV-1 Viral Factor HBZ Induces CCR4 to Promote T-cell Migration and Proliferation.
Sugata K; Yasunaga J; Kinosada H; Mitobe Y; Furuta R; Mahgoub M; Onishi C; Nakashima K; Ohshima K; Matsuoka M
Cancer Res; 2016 Sep; 76(17):5068-79. PubMed ID: 27402079
[TBL] [Abstract][Full Text] [Related]
38. HTLV-1 basic leucine zipper factor protects cells from oxidative stress by upregulating expression of Heme Oxygenase I.
Rushing AW; Rushing B; Hoang K; Sanders SV; Péloponèse JM; Polakowski N; Lemasson I
PLoS Pathog; 2019 Jun; 15(6):e1007922. PubMed ID: 31251786
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the role of
Akbarin MM; Shirdel A; Bari A; Mohaddes ST; Rafatpanah H; Karimani EG; Etminani K; Golabpour A; Torshizi R
Blood Res; 2017 Jun; 52(2):106-111. PubMed ID: 28698846
[TBL] [Abstract][Full Text] [Related]
40. Interferon-γ Promotes Inflammation and Development of T-Cell Lymphoma in HTLV-1 bZIP Factor Transgenic Mice.
Mitagami Y; Yasunaga J; Kinosada H; Ohshima K; Matsuoka M
PLoS Pathog; 2015 Aug; 11(8):e1005120. PubMed ID: 26296091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
